Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, Weston, FL, USA; Colorectal Surgery Unit, General Surgery Department, Mansoura University Hospitals, Mansoura, Egypt.
Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, Weston, FL, USA.
Eur J Surg Oncol. 2024 Nov;50(11):108618. doi: 10.1016/j.ejso.2024.108618. Epub 2024 Aug 23.
The National Accreditation Program for Rectal Cancer (NAPRC) recommends definitive treatment of rectal cancer commence within 60 days from diagnosis. This study aimed to assess predictors of >60 days delay between diagnosis and definitive surgery of rectal cancer and the impact on survival and short-term outcomes.
Retrospective cohort analysis of patients with stage I-III rectal adenocarcinoma who underwent proctectomy without preoperative neoadjuvant treatment from the National Cancer Database (2015-2019). Based on the time interval between diagnosis and definitive surgery, patients were divided into timely non-adherent (>60 days) and timely-adherent (≤60 days) groups. Multivariate analysis determined predictors of delayed definitive surgery.
9479 patients (57.5 % males; mean age: 63.7 years) had a 41-day median time between diagnosis and definitive surgery. Non-adherence was noted in 27.9 % of patients. Independent predictors of non-adherence were male sex (Odds ratio [OR]: 1.25; p < 0.001), Black (OR: 1.65; p < 0.001) or Asian (OR: 1.33; p = 0.014) race, Charlson score 2 (OR: 1.33; p = 0.005) or 3 (OR: 1.55; p < 0.001), urban residence (OR: 1.21; p = 0.003), abdominoperineal resection (OR: 1.69; p < 0.001), pelvic exenteration (OR: 1.7; p = 0.002), and robotic-assisted surgery (OR: 1.22; p = 0.001). Medicare (OR: 0.725; p = 0.003) and private insurance (OR: 0.711; p < 0.001) were associated with better adherence. 30-day and 90-day mortality, unplanned readmission, and overall survival were similar.
Male Black or Asian patients with high Charlson scores, and undergoing abdominoperineal resection, pelvic exenteration, and robotic-assisted surgery were more likely non-adherent with NAPRC standards with >60 days delay before definitive surgery for rectal cancer. Hopefully, recognition for these reasons for delay of definitive surgery will lead to an improvement in adherence to the standards.
国家直肠癌认证计划(NAPRC)建议从诊断之日起 60 天内开始对直肠癌进行确定性治疗。本研究旨在评估直肠癌诊断与确定性手术之间超过 60 天的延迟的预测因素,并评估其对生存和短期结果的影响。
回顾性分析了来自国家癌症数据库(2015-2019 年)的未接受术前新辅助治疗的 I-III 期直肠腺癌患者的队列。根据诊断和确定性手术之间的时间间隔,患者被分为及时非依从(>60 天)和及时依从(≤60 天)组。多变量分析确定了确定性手术延迟的预测因素。
9479 名患者(57.5%为男性;平均年龄:63.7 岁)的诊断与确定性手术之间的中位时间为 41 天。27.9%的患者存在非依从性。非依从性的独立预测因素包括男性(比值比[OR]:1.25;p<0.001)、黑种人(OR:1.65;p<0.001)或亚裔(OR:1.33;p=0.014)、Charlson 评分 2 分(OR:1.33;p=0.005)或 3 分(OR:1.55;p<0.001)、城市居住(OR:1.21;p=0.003)、腹会阴切除术(OR:1.69;p<0.001)、盆腔切除术(OR:1.7;p=0.002)和机器人辅助手术(OR:1.22;p=0.001)。医疗保险(OR:0.725;p=0.003)和私人保险(OR:0.711;p<0.001)与更好的依从性相关。30 天和 90 天死亡率、非计划再入院和总生存率相似。
男性、黑种人或亚裔、Charlson 评分高的患者,以及接受腹会阴切除术、盆腔切除术和机器人辅助手术的患者,在诊断后 60 天以上才进行直肠癌确定性手术的情况下,不太可能符合 NAPRC 标准。希望对这些延迟确定性手术的原因的认识,将导致对这些标准的依从性得到改善。